Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Ischemic conditions

Findings obtained from experimental studies suggest that induction of iNOS mediates inflammatory or ischemic brain damage and that excessively activated nNOS under excitotoxic or ischemic conditions produces NO that is toxic to surrounding neurons. Selective inhibition of iNOS or nNOS may be neuroprotec-tive. This is also the case in glaucoma and diabetic... [Pg.860]

Studies have now started to clarify the role of histamine Hi and H2 receptors in the cardiovascular manifestations of anaphylaxis. However, histamine can activate H3 and H4 receptors [56, 57]. Levi and coworkers [58-60] identified H3 receptors as inhibitory heteroreceptors in cardiac adrenergic nerve endings. This suggests a mechanism by which endogenous histamine can activate norepinephrine release in normal and ischemic conditions [61,62]. The functional identification ofH3 receptors in the human heart [59] means that these receptors might be directly and/or indirectly involved in the cardiovascular manifestations of anaphylactic reactions. [Pg.105]

The answer is a. (Hardman, pp 762-764.) Experimentally, nitrates dilate coronary vessels. This occurs in normal subjects, resulting in an overall increase in coronary blood flow. In arteriosclerotic coronaries, the ability to dilate is lost, and the ischemic area may actually have less blood flow under the influence of nitrates. Improvement in the ischemic conditions is the result of decreased myocardial oxygen demand because of a reduction of preload and afterload. Nitrates dilate both arteries and veins and thereby reduce the work of the heart. Should systemic blood pressure fall, a reflex tachycardia will occur. In pure coronary spasm, such as Prinzmetal s angina, the effect of increased coronary blood flow is relevant, while in severe left ventricular hypertrophy with minimal obstruction, the effect on preload and afterload becomes important. [Pg.132]

P5 Studies have shown that ebselen is an antiinflammatory and antioxidative agent. Its protective effect has been investigated in oxidative stress related diseases such as cerebral ischemia in recent years. However, experimental evidence also shows that ebselen causes cell death in several different cell types. Whether ebselen will have a beneficial or detrimental effect on cells under ischemic condition is not known. Herein, we studied the effect of ebselen... [Pg.249]

Alterations in energy metabolism are known to occur during ischemic conditions which have been associated with pathologies such as stroke, migraine, and perinatal hypoxia-ischemia (Ffl). Phosphorus-31 MRS... [Pg.134]

Flecainide Sodium channel (INa) blockade Dissociates from channel with slow kinetics no change in action potential duration Supraventricular arrhythmias in patients with normal heart do not use in ischemic conditions (post-myocardial infarction) Oral hepatic, and kidney metabolism half life 20 h Toxicity Proarrhythmic... [Pg.295]

Hypoxic or ischemic conditions led to an immediate release of free choline via the breakdown of choline-containing phospholipids in rat hippocampus slices. Klein et d. [198] showed that bilobalide inhibited the hypoxia-induced choline release in a dose-dependent manner both in vitro (EC,0 0.38 /rM) and ex vivo (2-20 mg/kg, p.o.). Asimilar reduction of choline release was confirmed after administration of EGb (200 mg/kg, p.o.). Bilobalide also inhibits die //-methyl-D-aspartate-induced, P LA,-dependent release of choline from hippocampal phospholipids both in vitro (10-100/rM) and in vivo (20 mg/kg, ip.) [199]. [Pg.188]

Orally administered L-carnitine and propionyl-L-carnitine may have metabolic benefits by providing an additional source of carnitine to buffer the cellular acyl CoA pool. In this way, carnitine may enhance glucose oxidation under ischemic conditions and improve energy metabolism in the ischemic skeletal muscle. Propionyl-CoA generated from propionyl-L-carnitine may also improve oxidative metabolism through its anaphoretic actions in priming the Kreb s cycle, secondary to succinyl-CoA production. [Pg.519]

Thus, our findings demonstrate that MS is neuroprotective in both in vivo and in vitro ischemic conditions, through a mechanism which may involve increased endogenous levels of H202 and its consequent conversion to molecular oxygen by catalase. [Pg.364]

Pathological activation of glutamate receptors is a common feature and one of the primary causes of neuronal death in acute neuronal injury (such as trauma, epilepsy, and brain ischemia) and chronic neurodegenerative diseases (such as Parkinson s disease, Alzheimer diseases, amyotrophic lateral sclerosis, and AIDS dementia) (Choi, 1988 Doble, 1999 Lipton and Rosemberg, 1994). In particular, elevation of extracellular glutamate level is a key factor in the development of neuronal damage under ischemic conditions. [Pg.408]

Several evidence underlie the crucial role of excessive glutamate release under ischemic conditions in the brain (Aarts el al., 2003 Camacho and Massieu, 2006 Dirnagl et al., 1999) and, concurrently, experimental data sustain a comparable role for glutamate under retinal ischemia (Adachi et al., 1998 Louzada-Junior et al., 1992). However, it should be stressed that the mechanisms underlying tolerance to ischemia may differ in brain and in the retina, the latter being more tolerant to ischemia than the former (Iijima et al., 2000 Osborne et al., 2004). [Pg.409]

Under ischemic conditions, accumulation of pathological levels of glutamate is accompanied by an early and robust activation of the proteolytic, calcium-dependent, enzyme calpain (Branca, 2004) that is maintained over 24-h period of reperfusion (Oka et al., 2006 Sakamoto et al., 2000) and is prevented by treatment with the NMDA receptor antagonist MK801 (Russo and Morrone, personal communication). [Pg.413]

We performed delayed CT after the administration of contrast medium in 11 patients with both ALPE and renal hypouricemia. In 10 of the 11 patients, patchy renal ischemia was noted [4], suggesting that renal ischemic conditions after anaerobic exercise were similar regardless of the presence or absence of renal hypouricemia. [Pg.63]

Fig. 4.6. Quantitative maps of the apparent diffusion coefficient (ADC) in cats subjected to 1-h complete cerebrocir-culatory arrest followed by 180 min of recirculation. Each row represents one animal. The pre-ischemic condition is shown by the first left column. Images show a central coronal slice that was measured at six time points per animal. Note the early decline of ADC after onset of ischemia and the rapid post-ischemic normalization in the lower three rows indicating recovery in those animals. The upper two rows depict animals that did not recover during the reperfusion phase. [Reproduced with permission from Hossmann et al. (1994)]... Fig. 4.6. Quantitative maps of the apparent diffusion coefficient (ADC) in cats subjected to 1-h complete cerebrocir-culatory arrest followed by 180 min of recirculation. Each row represents one animal. The pre-ischemic condition is shown by the first left column. Images show a central coronal slice that was measured at six time points per animal. Note the early decline of ADC after onset of ischemia and the rapid post-ischemic normalization in the lower three rows indicating recovery in those animals. The upper two rows depict animals that did not recover during the reperfusion phase. [Reproduced with permission from Hossmann et al. (1994)]...
Thus, PI is a particularly important tool in DWI negative vascular events and non-ischemic strokelike episodes and may, indeed, clarify the underlying pathology. The majority of patients with DWI negative scans can be classified correctly based on PI as suffering from a cerebrovascular event or from a stroke mimic. Negative DWI and PI studies should intensify the search for non-ischemic conditions. However, in the majority of stroke patients DWI will reveal the clinically relevant lesion and has now become the centerpiece of integrated stroke MRI examinations. [Pg.128]

Characterize the various physiological changes resulting from mild hypothermia under each experimental ischemic condition including effects on metabolism, cerebral blood flow, and BBB alterations. [Pg.4]

The intracellular pH in the myocardial tissue during ischemia reportedly falls to 6.4 therefore, the PBN/ OH should be relatively more persistent under ischemic conditions as opposed to reperfusion. In aqueous solution, the decomposition of PBN/ OH is facilitated due to the ease with which the acidic (3-proton is dissociated. In contrast, the unimolecular decomposition of PBN/ OH becomes energetically difficult in non-protic solvents such as toluene and benzene. This may well account for the increased stability of PBN/ OH adduct in these solvents. [Pg.348]

Another report has provided more details from physical assessments and laboratory and radiological (MRI and MRS) data, and more information about the course of this heroin-related effect (21). The three cases showed raised concentrations of intracerebral lactate (reflecting mitochondrial dysfunction), which suggests a conversion of aerobic to anaerobic metabolism seen in hypoxic-ischemic conditions, including stroke. One patient recovered quite well after antioxidant therapy, supporting a metabolic effect of the heroin-related toxin a similar response to co-enzyme Q has been found in other mitochondrial disorders with a high CSF lactate. Thus, the authors recommended that although the role of antioxidant therapy in this condition is unclear, it may be prudent to administer oral co-enzyme Q supplemented with vitamins C and E to patients with this syndrome. [Pg.543]

Kaur C, Ling EA (2008) Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res 5 71-81... [Pg.161]


See other pages where Ischemic conditions is mentioned: [Pg.171]    [Pg.20]    [Pg.424]    [Pg.278]    [Pg.22]    [Pg.119]    [Pg.132]    [Pg.139]    [Pg.565]    [Pg.105]    [Pg.179]    [Pg.95]    [Pg.176]    [Pg.177]    [Pg.200]    [Pg.328]    [Pg.68]    [Pg.122]    [Pg.442]    [Pg.285]    [Pg.410]    [Pg.286]    [Pg.154]    [Pg.54]    [Pg.53]    [Pg.164]    [Pg.627]    [Pg.20]    [Pg.424]    [Pg.196]   


SEARCH



Ischemic

© 2024 chempedia.info